Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: Mid-frontal Delta/Theta and Cognitive Control [NA]

View source ↗

Summary

An ongoing clinical trial evaluating mid-frontal delta/theta activity and cognitive control in Parkinson's disease, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nandakumar Narayanan | Conditions: Parkinson&Amp;Amp;#39;s Disease (PD) | NA | Status: ENROLLING_BY_INVITATION